Aim of this work was the implementation and alidation, for the Discovery-ST PET/CT (GE Medical Systems) ystem, of the acquisition-specific noise equivalent counts AS-NEC) method to establish the amount of tracer to be injected n 3D 18F-FDG whole body (WB) PET studies to achieve the peak of the NEC (NEC-p) at the acquisition time. The AS-NEC method ses prompts, delayed events and detector dead-time of a single eference PET scan to calculate the full shape of the NEC curve. The method was implemented using a 3D decay series of the 70 cm EMA 2001 (line source in a 20 cm diameter solid polyethylene ylinder) phantom and validated with the cylindrical NEMA 994 (diameter, 20 cm; length, 20 cm) and NEMA 2001 IEC body hantoms. The NEC curves generated by the single frames of the hantom series, using the AS-NEC method, well correlated with the experimental NEC curves proving the validity of the method nd the possible application to clinical studies. The AS-NEC model as then retrospectively applied on 40 3D 18F-FDG WB studies n a range of body mass index (BMI) between 16 and 30 (kg/m2) 6 under-weight (uw), 18 normal-weight (nw), 16 over-weight ow)). For each acquisition frame of each patient study, the activity at the acquisition time, corresponding to the NEC-p was identified on the NEC curves. Furthermore, as the NEC curves show a region around the NEC-p with small variations (nearly a plateau), the values of radioactivity corresponding to a reduction of 1%, 3% and 5% with respect to NEC-p were also calculated to assess a possible reduction of the doses to be injected in clinical studies. The results show that the average activities at the acquisition time corresponding to the NEC-p were comparable for the three BMI classes: 336.7 MBq (sd = 22 2) 329 3 MBq (sd = 33 3) 344 1 MBq (sd = 48 1) for uw, nw and ow, respectively. Therefore, the total average NEC-p activity for the three BMI classes was 336.7 MBq (sd = 40 7). The mean values of the radioactivity at a reduction of 1%, 3% and 5% with respect to the NEC-p were: 284.9 MBq (sd = 40 7) 247 9 MBq (sd = 33 3) and 225.7 MBq (sd = 29 6) respectively. These results indicate the possibility to use, for the Discovery-ST, a single injection protocol of 448 MBq (for the range of BMI here considered) to have an activity at the acquisition time (after 45 min of uptake) of 336.7 MBq (NEC-p). Nevertheless, the plateau near the NEC-p suggests the possibility to reduce significantly the dose to be injected in clinical studies down to about 330 MBq, while preserving suitable NEC performance ( 3%) with respect to the NEC-p. This result was supported by image quality assessment performed on reconstructed images of the NEMA 2001 IEC body phantom.
Generation of the acquisition-specific NEC (AS-NEC) curves to optimize the injected dose in 3D 18F-FDG whole body PET studies
Gilardi MC;Fazio F
2006
Abstract
Aim of this work was the implementation and alidation, for the Discovery-ST PET/CT (GE Medical Systems) ystem, of the acquisition-specific noise equivalent counts AS-NEC) method to establish the amount of tracer to be injected n 3D 18F-FDG whole body (WB) PET studies to achieve the peak of the NEC (NEC-p) at the acquisition time. The AS-NEC method ses prompts, delayed events and detector dead-time of a single eference PET scan to calculate the full shape of the NEC curve. The method was implemented using a 3D decay series of the 70 cm EMA 2001 (line source in a 20 cm diameter solid polyethylene ylinder) phantom and validated with the cylindrical NEMA 994 (diameter, 20 cm; length, 20 cm) and NEMA 2001 IEC body hantoms. The NEC curves generated by the single frames of the hantom series, using the AS-NEC method, well correlated with the experimental NEC curves proving the validity of the method nd the possible application to clinical studies. The AS-NEC model as then retrospectively applied on 40 3D 18F-FDG WB studies n a range of body mass index (BMI) between 16 and 30 (kg/m2) 6 under-weight (uw), 18 normal-weight (nw), 16 over-weight ow)). For each acquisition frame of each patient study, the activity at the acquisition time, corresponding to the NEC-p was identified on the NEC curves. Furthermore, as the NEC curves show a region around the NEC-p with small variations (nearly a plateau), the values of radioactivity corresponding to a reduction of 1%, 3% and 5% with respect to NEC-p were also calculated to assess a possible reduction of the doses to be injected in clinical studies. The results show that the average activities at the acquisition time corresponding to the NEC-p were comparable for the three BMI classes: 336.7 MBq (sd = 22 2) 329 3 MBq (sd = 33 3) 344 1 MBq (sd = 48 1) for uw, nw and ow, respectively. Therefore, the total average NEC-p activity for the three BMI classes was 336.7 MBq (sd = 40 7). The mean values of the radioactivity at a reduction of 1%, 3% and 5% with respect to the NEC-p were: 284.9 MBq (sd = 40 7) 247 9 MBq (sd = 33 3) and 225.7 MBq (sd = 29 6) respectively. These results indicate the possibility to use, for the Discovery-ST, a single injection protocol of 448 MBq (for the range of BMI here considered) to have an activity at the acquisition time (after 45 min of uptake) of 336.7 MBq (NEC-p). Nevertheless, the plateau near the NEC-p suggests the possibility to reduce significantly the dose to be injected in clinical studies down to about 330 MBq, while preserving suitable NEC performance ( 3%) with respect to the NEC-p. This result was supported by image quality assessment performed on reconstructed images of the NEMA 2001 IEC body phantom.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
